GlassScriptPhysician profile
Aaron D Losey
NPI 1326468216
$7,995.61
in general payments reported to CMS, 2019-2025
12 companies · $3,064 in 2025
The $3,064 reported for 2025 was more than what 92% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.80 · 2020: $18.69 · 2021: $120 · 2022: $651 · 2023: $931 · 2024: $3,145 · 2025: $3,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,072 · Food and Beverage: $3,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,071.80 |
| Food and Beverage | $3,069.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,659.90 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Ge Healthcare | $1,198.91 | 2024-2025 | |
| Philips North America LLC | $1,027.57 | 2025 | Azurion 5 M20 |
| Sirtex Medical INC | $893.77 | 2020-2025 | Lava Les (Liquid Embolic System) |
| Cardiovascular Systems INC. | $589.82 | 2022 | |
| Medtronic, INC. | $354.85 | 2024-2025 | Abre, Hawkone, Concertotm |
| Progenics Pharmaceuticals, INC. | $103.70 | 2023 | Pylarify |
| Angiodynamics, INC. | $49.52 | 2021 | |
| Bard Peripheral Vascular, INC. | $38.52 | 2023 | Pristine, Venovo |
| Abbott Laboratories | $36.84 | 2022 | |
| Celgene Corporation | $28.80 | 2024 | Reblozyl |
| Cook Medical LLC | $13.41 | 2024 | Torcon Nb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Losey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.